enthusiasm:40.0 · trend:8 · quantifies:12 · impact:0 · under_radar:0 · credibility:12 · business_impact:8 · commitment:6 · confirmation:4
Enthusiasm latest 10 / prev 9 (rising)
IBM frames AI not as a standalone app bet but as enterprise plumbing—hybrid orchestration, governed data-in-motion (Confluent/watsonx), automation/control planes, and in-line mainframe inferencing (Spyre/Z)—with model neutrality ('Switzerland'). Management backs the thesis with unusually concrete metrics: $1.5B+ software AI revenue growing 40%+, consulting GenAI at $4B ARR and ~30% of backlog, and AI-linked MIPS/Z17 pull-through. Credibility is strengthened by repeated quantification and client-zero proof (Bob at 45% productivity, $4.5B internal savings), though much consulting AI revenue remains services-heavy and the standalone $12.5B cumulative book metric was retired as AI became embedded.
Grounded on actual base — revenue $67.5B · net income $10.6B · net margin 15.7% · diluted EPS 11.17
These are next-fiscal-year annual uplift estimates, not next-quarter numbers.
Aggregate next-FY est. rev uplift: 1.604% · next-FY EPS uplift: 10.281% · vs analysts: inline · priced in: high · confidence: 6/10
| Claim | Figure | Arithmetic | Next-FY Rev % | Next-FY EPS % |
|---|---|---|---|---|
| Internal productivity savings (transformation engine) productivity | $4.5B cumulative since 2023; +$1B expected in 2026 | Next-FY (FY2026) incremental only: $1.0B pre-tax × (1−0.21) = $790M after-tax; EPS uplift = $790M / $10,593M NI = 7.46%; rev uplift = $0 / $67,535M = 0%. Cumulative $4.5B is historical stock, not FY26 increment. | 0 | 7.458 |
| IBM Bob developer productivity productivity · soft | 45% average productivity gains; entire developer workforce | Percent productivity with no wage base, FTE count, or $ savings stated; cannot convert to $/NI without invented inputs → null. | ||
| Software AI platform revenue (agents/orchestration) revenue | North of $1.5B TTM; ~25% penetrated; >40% growth; 2 pts software growth | Stock: $1.5B / $67,535M = 2.22% of company rev (already in base, not incremental). Incremental FY26 (hard): +2 pts on software ≈ $28.28B × 2% = $565.6M → $565.6M / $67,535M = 0.84% rev; @30% incr net margin (software) → $169.7M / $10,593M NI = 1.60% EPS. Alt YoY on platform: $1.5B × 40% = $600M = 0.89% rev / 1.70% EPS — overlaps 2-pt contribution; not summed in aggregate. | 0.838 | 1.602 |
| Consulting GenAI backlog penetration engagement · soft | ~30% of backlog | Mix only; $32B consulting backlog (Q4 FY25) × 30% = $9.6B GenAI backlog stock — no FY26 revenue recognition rate or net-new $ stated → null. | ||
| Consulting GenAI ARR revenue · soft | Eclipsed $4 billion ARR in Q1 | Stock run-rate: $4.0B / $67,535M = 5.93% of total rev (embedded). Incremental FY26 phasing assumption: +20% YoY on $4B exit = $800M incr rev → $800M / $67,535M = 1.18% rev; @15% incr net margin (consulting) → $120M / $10,593M = 1.13% EPS. Step-up Q4 exit $3.6B → Q1 $4.0B = $400M (too short to annualize). | 1.185 | 1.133 |
| Consulting GenAI signings/backlog/revenue mix engagement · soft | ~40% signings; 30% backlog; >20% revenue | Mix metrics; ~20% of consulting rev ≈ $4B ARR (consistent with $4B ARR claim) but no incremental $ for FY26 → null. | ||
| Mainframe AI inferencing capacity other · soft | ~450 billion inferences per day | Technical throughput; no $ revenue or savings per inference stated → null. | ||
| watsonx Code Assistant for Z MIPS growth engagement · soft | 3x faster MIPS capacity growth vs non-deployed | Client cohort differential; no IBM revenue $ or MIPS $ attach rate → null. | ||
| Real-time fraud detection client savings other · soft | Tens of millions of dollars (client savings) | Customer P&L benefit, not IBM revenue/opex; unbounded 'tens of millions' → null per guardrail. | ||
| Data segment growth (GenAI-driven) revenue | 16% Q1; guided low 20%+ for FY2026 | Segment map: Data ≈ $5.75B FY25 base. Incremental FY26 vs ~11% baseline trend: (20%−11%) × $5.75B = $517.3M → $517.3M / $67,535M = 0.77% rev; @25% incr net margin → $129.3M / $10,593M = 1.22% EPS. | 0.766 | 1.221 |
| Z17 new MIPS shipments engagement · soft | >100% growth of new MIPS for 4 consecutive quarters | Unit/volume growth rate without Systems revenue $ or incremental FY26 $ → null. | ||
| Cumulative GenAI book of business revenue · soft | Over $12.5B ($2B+ software; $10.5B+ consulting) | Cumulative bookings stock: $12.5B / $67,535M = 18.5% of LTM rev if recognized in one year (not realistic). No FY26 recognition % stated → null for next-FY P&L. | ||
| Consulting GenAI quarterly book revenue · soft | Surpassed $2 billion in the quarter (Q4 FY2025) | Bookings flow ($2B/qtr ≈ $8B annualized), not revenue; recognition phasing unknown → null. | ||
| Consulting GenAI ARR run rate (exit Q4) revenue · soft | $3.6 billion | Superseded by $4.0B Q1 ARR; stock metric. Q4→Q1 step +$400M ARR — not full-year FY26 increment alone → not additive to ARR growth claim above. | ||
| Consulting GenAI mix (exit Q4) engagement · soft | >⅓ bookings; >25% backlog; >15% revenue | Mix on $32B backlog / consulting rev; no incremental FY26 $ beyond ARR/book claims → null. | ||
| Project Bob internal productivity productivity · soft | 20,000+ IBMers; 45% average productivity gains | Mechanism for transformation-engine savings; overlaps $1B FY26 productivity claim — not double-counted. | ||
| Z17 vs Z16 AI inferencing throughput other · soft | 50% more AI inferencing operations per day | Product spec; no $ attach → null. | ||
| Productivity savings run-rate target by 2026 productivity · soft | $5.5B annual run rate by 2026 (+$1B incremental in 2026) | Duplicate of +$1B FY26 incremental (same arithmetic as first claim); $5.5B is cumulative run-rate target, not extra FY26 $ beyond $1B. | 0 | |
| Software GenAI book of business revenue · soft | Over $2 billion; up 2x in Q4 | Bookings stock; overlaps software AI platform revenue. No FY26 revenue recognition % → null. |
Assumptions: Next fiscal year = FY2026 (year ending 2026-12-31). LTM base: rev $67.535B, NI $10.593B, net margin 15.69%. Tax rate 21% on productivity saves (after-tax factor 0.79). Incremental margins: software/AI platform 30%; Data 25%; default 15.69% not used where segment-specific. Software rev proxy $28.28B for '2 points of growth' (= +2pp on growth rate ≈ 2% × segment rev). Data segment $5.75B; FY26 guide 'low 20%+' vs ~11% baseline → +9pp incremental growth. Consulting GenAI ARR: +20% YoY on $4B exit (soft phasing). Productivity: only +$1B FY26 incremental counted once. Bookings/ARR stock, mix %, MIPS/inferencing, and Bob 45% excluded from aggregate to avoid double-count. Confluent ~$600M FY26 dilution (forward statement) not modeled in uplift.
Top line: Hard FY26 revenue math sums non-overlapping items: software AI +2 pts ≈ $565.6M (0.84% of $67.535B) + Data GenAI-driven extra growth ≈ $517.3M (0.77%) = ~1.60% company rev uplift (~$1.08B). Existing run-rates ($1.5B+ software AI platform, $4B consulting GenAI ARR) are already ~8% of LTM rev and not incremental. Bookings ($12.5B cumulative, $2B/qtr consulting) and mix metrics do not add defensible FY26 P&L without invented recognition rates.
Bottom line: Dominant hard bottom-line item: $1.0B FY26 productivity savings → $790M after-tax → +7.46% vs LTM NI; topline 0% unless reinvested. Software (+1.60% EPS) and Data (+1.22% EPS) add ~2.8% EPS on LTM base. Aggregate hard EPS uplift ≈10.3% on LTM NI (~$1.09B), before optional +1.13% EPS from assumed +20% consulting GenAI ARR growth (soft). $1B productivity alone is ~70% of consensus FY25→FY26 NI increase ($1.13B).
FY2025 actuals: rev $67.535B, EPS $11.17, NI $10.593B. FY2026 consensus: rev $71.467B (+5.82% / +$3.93B), EPS $12.44 (+11.34%), NI $11.723B (+10.67%). Hard AI-attributable FY26 uplift ≈1.60% rev and ≈10.3% EPS on LTM base — revenue math is well below consensus +5.82% (gap ~4.2pp), implying analysts already embed mainframe cycle, Confluent, and broader software/consulting growth beyond identifiable AI claims. EPS bridge is essentially inline: 10.3% modeled vs 11.3% consensus NI growth; $790M after-tax productivity ≈70% of the $1.13B consensus NI step. Optional consulting ARR +20% would lift totals to ~2.79% rev / ~11.4% EPS — still rev-light vs consensus. Forward Confluent ~$600M dilution is a headwind not in positive AI math. Priced-in high: quantified AI is largely run-rate disclosure plus $1B opex save already consistent with consensus EPS path.
86/100 track record delivers 7 calls reviewed
IBM rarely sets dated GenAI revenue targets; credibility rests mainly on productivity and infrastructure AI milestones, which they met or beat ($3.5B then $4.5B savings, z17 on time). Software growth came close but consulting/quantum items are partial or still open.
Est. revisions rising · Fwd P/E 28.7 · EV/Sales 5.3x
AI claim maps to Software, Consulting, Infrastructure Services
AI enthusiasm across 6 calls — trend ↗ rising
GenAI book grew $5B to $12.5B+ with deeper agentic platform, z17 inferencing, and $4.5B internal productivity proof.
8/10 qualitative impact material near-term · mixed evidence
Where AI matters: watsonx/software AI platform, GenAI consulting delivery, internal productivity, Z mainframe inferencing
Disclosed run-rates (~$1.5B+ software AI platform, ~$4B consulting GenAI ARR, ~30% consulting backlog) and a credible $1B FY26 internal savings line show AI is operating across software, services, and cost—not slideware; incremental FY26 revenue math (~1.6% of ~$67.5B) and services-heavy consulting mix cap how company-transforming the topline looks versus the narrative.
Caveats: Consulting GenAI ARR and backlog mix may be labor-augmented services with weaker margin and retention than platform software; Incremental identifiable AI revenue is small versus total growth and consensus, so cycle/Confluent/mainframe could dominate outcomes; Mainframe inference/MIPS metrics (e.g., 450B inferences/day, 3x MIPS cohort) lack clean IBM revenue attribution; Retired cumulative AI bookings metric and embedded AI reporting reduce transparency as claims get harder to audit
option liquidity: good
proxy inputs — dollar-ADV $2.3B · beta 0.581 · px $326.09
source: proxy (no options chain on FMP)
FMP /stable/ exposes no options-chain endpoint on this key, so ATM IV, bid-ask spread and open interest are unavailable. Liquidity below is a PROXY from dollar-ADV, beta and price level (a stand-in for option depth), not measured option-market data.